Literature DB >> 19338303

Structural insight into the inhibition of human kynurenine aminotransferase I/glutamine transaminase K.

Qian Han1, Howard Robinson, Tao Cai, Danilo A Tagle, Jianyong Li.   

Abstract

Human kynurenine aminotransferase I (hKAT I) catalyzes the formation of kynurenic acid, a neuroactive compound. Here, we report three high-resolution crystal structures (1.50-1.55 A) of hKAT I that are in complex with glycerol and each of two inhibitors of hKAT I: indole-3-acetic acid (IAC) and Tris. Because Tris is able to occupy the substrate binding position, we speculate that this may be the basis for hKAT I inhibition. Furthermore, the hKAT/IAC complex structure reveals that the binding moieties of the inhibitor are its indole ring and a carboxyl group. Six chemicals with both binding moieties were tested for their ability to inhibit hKAT I activity; 3-indolepropionic acid and DL-indole-3-lactic acid demonstrated the highest level of inhibition, and as they cannot be considered as substrates of the enzyme, these two inhibitors are promising candidates for future study. Perhaps even more significantly, we report the discovery of two different ligands located simultaneously in the hKAT I active center for the first time.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19338303      PMCID: PMC2844090          DOI: 10.1021/jm9000874

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  50 in total

1.  wARP: improvement and extension of crystallographic phases by weighted averaging of multiple-refined dummy atomic models.

Authors:  A Perrakis; T K Sixma; K S Wilson; V S Lamzin
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1997-07-01

Review 2.  Endogenous kynurenines as targets for drug discovery and development.

Authors:  Trevor W Stone; L Gail Darlington
Journal:  Nat Rev Drug Discov       Date:  2002-08       Impact factor: 84.694

3.  Renal cysteine conjugate C-S lyase mediated toxicity of halogenated alkenes in primary cultures of human and rat proximal tubular cells.

Authors:  Trevor A McGoldrick; Edward A Lock; Vicente Rodilla; Gabrielle M Hawksworth
Journal:  Arch Toxicol       Date:  2003-04-17       Impact factor: 5.153

4.  The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications.

Authors:  C Hilmas; E F Pereira; M Alkondon; A Rassoulpour; R Schwarcz; E X Albuquerque
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

5.  pH dependence, substrate specificity and inhibition of human kynurenine aminotransferase I.

Authors:  Qian Han; Junsuo Li; Jianyong Li
Journal:  Eur J Biochem       Date:  2004-12

6.  Early kynurenergic impairment in Huntington's disease and in a transgenic animal model.

Authors:  P Guidetti; P H Reddy; D A Tagle; R Schwarcz
Journal:  Neurosci Lett       Date:  2000-04-14       Impact factor: 3.046

7.  Increased cortical kynurenate content in schizophrenia.

Authors:  R Schwarcz; A Rassoulpour; H Q Wu; D Medoff; C A Tamminga; R C Roberts
Journal:  Biol Psychiatry       Date:  2001-10-01       Impact factor: 13.382

8.  Kynurenic acid blocks nicotinic synaptic transmission to hippocampal interneurons in young rats.

Authors:  Trevor W Stone
Journal:  Eur J Neurosci       Date:  2007-04-25       Impact factor: 3.386

Review 9.  The kynurenine pathway of tryptophan degradation as a drug target.

Authors:  Robert Schwarcz
Journal:  Curr Opin Pharmacol       Date:  2004-02       Impact factor: 5.547

10.  Biochemical and structural properties of mouse kynurenine aminotransferase III.

Authors:  Qian Han; Howard Robinson; Tao Cai; Danilo A Tagle; Jianyong Li
Journal:  Mol Cell Biol       Date:  2008-11-24       Impact factor: 4.272

View more
  19 in total

1.  Biochemical and structural characterization of mouse mitochondrial aspartate aminotransferase, a newly identified kynurenine aminotransferase-IV.

Authors:  Qian Han; Howard Robinson; Tao Cai; Danilo A Tagle; Jianyong Li
Journal:  Biosci Rep       Date:  2011-10       Impact factor: 3.840

Review 2.  Structure, expression, and function of kynurenine aminotransferases in human and rodent brains.

Authors:  Qian Han; Tao Cai; Danilo A Tagle; Jianyong Li
Journal:  Cell Mol Life Sci       Date:  2009-10-15       Impact factor: 9.261

3.  High resolution crystal structures of human kynurenine aminotransferase-I bound to PLP cofactor, and in complex with aminooxyacetate.

Authors:  Naveed A Nadvi; Noeris K Salam; Joohong Park; Fady N Akladios; Vimal Kapoor; Charles A Collyer; Mark D Gorrell; William Bret Church
Journal:  Protein Sci       Date:  2017-03-06       Impact factor: 6.725

4.  A small-molecule screen identifies L-kynurenine as a competitive inhibitor of TAA1/TAR activity in ethylene-directed auxin biosynthesis and root growth in Arabidopsis.

Authors:  Wenrong He; Javier Brumos; Hongjiang Li; Yusi Ji; Meng Ke; Xinqi Gong; Qinglong Zeng; Wenyang Li; Xinyan Zhang; Fengying An; Xing Wen; Pengpeng Li; Jinfang Chu; Xiaohong Sun; Cunyu Yan; Nieng Yan; De-Yu Xie; Natasha Raikhel; Zhenbiao Yang; Anna N Stepanova; Jose M Alonso; Hongwei Guo
Journal:  Plant Cell       Date:  2011-11-22       Impact factor: 11.277

5.  Kynurenine aminotransferase III and glutamine transaminase L are identical enzymes that have cysteine S-conjugate β-lyase activity and can transaminate L-selenomethionine.

Authors:  John T Pinto; Boris F Krasnikov; Steven Alcutt; Melanie E Jones; Thambi Dorai; Maria T Villar; Antonio Artigues; Jianyong Li; Arthur J L Cooper
Journal:  J Biol Chem       Date:  2014-09-17       Impact factor: 5.157

6.  Thermal stability, pH dependence and inhibition of four murine kynurenine aminotransferases.

Authors:  Qian Han; Tao Cai; Danilo A Tagle; Jianyong Li
Journal:  BMC Biochem       Date:  2010-05-19       Impact factor: 4.059

7.  Marine Bacterial Compounds Evaluated by In Silico Studies as Antipsychotic Drugs Against Schizophrenia.

Authors:  Dhinesh Kumar Thiyagarajamoorthy; Charli Deepak Arulanandam; Hans-Uwe Dahms; Santhosh Gokul Murugaiah; Muthukumar Krishnan; Arthur James Rathinam
Journal:  Mar Biotechnol (NY)       Date:  2018-07-18       Impact factor: 3.619

Review 8.  Kynurenines, neurodegeneration and Alzheimer's disease.

Authors:  Zsigmond Tamas Kincses; József Toldi; László Vécsei
Journal:  J Cell Mol Med       Date:  2010-07-12       Impact factor: 5.310

9.  Structural basis for substrate specificity in ArnB. A key enzyme in the polymyxin resistance pathway of Gram-negative bacteria.

Authors:  Myeongseon Lee; Marcelo C Sousa
Journal:  Biochemistry       Date:  2014-01-24       Impact factor: 3.162

10.  Assessment of the Human Kynurenine Pathway: Comparisons and Clinical Implications of Ethnic and Gender Differences in Plasma Tryptophan, Kynurenine Metabolites, and Enzyme Expressions at Baseline and After Acute Tryptophan Loading and Depletion.

Authors:  Abdulla A-B Badawy; Donald M Dougherty
Journal:  Int J Tryptophan Res       Date:  2016-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.